Rio Grande Valley Ovarian Cycle
Join us September 13th at TRYBE Cycle.
Read more about Rio Grande Valley Ovarian Cycle Register now
Start or Join a Fitness Fundraiser for Ovarian Cancer
Ovarian Fitness Fundraisers
Being fit feels good but imagine how much better you’ll feel knowing your workout is helping the fight against ovarian and related gynecologic cancers. Whether you love to spin, run, dance, or bike, dedicate your next sweat session to raising your heart rate, and raising funds for a worthy cause.
Want to Create an Ovarian Fitness Event?
Bring an event to your community, or sign up to be notified when an event comes to your area! Our team is available to help you.
Upcoming Fitness Fundraisers
Tampa Ovarian Cycle
Join us September 20th at Union Three.
Washington D.C. Ovarian Fitness
Join us September 20th at VIDA Fitness – The Yards.
Read more about Washington D.C. Ovarian Fitness Register now.
Virginia Beach Fitness & Fight
Join us the week of September 21st to take on virtual fitness and fundraising challenges.
Read more about Virginia Beach Fitness & Fight Register now.
Houston Hope Ovarian Fitness
Join us September 27th at The Studio BE Montrose.
Orlando Ovarian Fitness
Join us September 27th at Studio SOUL.
Massapequa Ovarian Cycle
Click to get email alerts.
Jackson Ovarian Cycle
Click to get email alerts.
Denver Ovarian Cycle
Click to get email alerts.
Adirondacks Ovarian Cycle
Click to get email alerts.
Read more about Adirondacks Ovarian Cycle Sign up for alerts
NYC Ovarian Cycle
Click to get email alerts
I ride in Ovarian Fitness events to help raise funds for research and bring awareness to this awful disease. Fighting cancer is a team sport.
– Scott
Related Topics
OCRA President & CEO Audra Moran Named Crain’s 2026 Notable Leader in Health Care
Audra Moran, President and CEO of Ovarian Cancer Research Alliance (OCRA), has been recognized as a Crain’s New York Business 2026 Notable Leader in Health Care. Crain’s annual recognition spotlights health care executives whose leadership, innovation, and community commitment set a high bar for the field. Honorees are selected based on demonstrated impact, both within … Continued
OCRA Sponsors NCCN Guidelines for Cervical, Ovarian, and Uterine Cancer Patients
This article was updated in April 2026 to reflect NCCN’s release of the 2026 Guidelines for Uterine Cancer Patients. OCRA is a proud sponsor of the 2026 Patient Guidelines for Cervical Cancer and Uterine Cancer, and the 2025 Patient Guidelines for Ovarian. We believe ensuring access to clear, understandable information is critical. NCCN provides wonderful … Continued
FDA Approves Lifyorli Plus Abraxane for Platinum-Resistant Ovarian Cancer
On March 25, 2026, the U.S. Food and Drug Administration (FDA) approved Lifyorli (relacorilant), made by Corcept Therapeutics, in combination with Abraxane (nab-paclitaxel) for adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received one to three prior lines of treatment, including prior Avastin (bevacizumab). The approval follows last month’s FDA … Continued